<DOC>
	<DOCNO>NCT00571727</DOCNO>
	<brief_summary>Long term study effect dose rhIGF-1 growth</brief_summary>
	<brief_title>Long-Term Treatment With rhIGF-1 GHIS</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Laron Syndrome</mesh_term>
	<criteria>Height &lt; 2SD age gender IGF1 &lt; 2SD age gender Evidence GH resistance close epiphysis prior active malignancy major organ disfunction treatment medication would diminish growth clinically significant cardiac abnormality</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>growth</keyword>
	<keyword>insulin like growth factor</keyword>
	<keyword>Larons syndrome</keyword>
</DOC>